Verily Appoints Health Data Expert and Former FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD as President of Verily’s Clinical Research Platforms

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Verily, an Alphabet company, today announced the appointment of Amy Abernethy, M.D., Ph.D. as President of Verily’s clinical research business. Verily’s clinical research started with the Baseline program, a suite of studies using patient-centric tools for research data collection. Today’s announcement foreshadows Verily’s planned expansion into...

Click to view original post